PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain.\', \'Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.\', \'TriNetX LLC., Cambridge, MA, United States.\', \'TriNetX LLC., London, United Kingdom.\', \'Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain.\', \'Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: gregory.lip@liverpool.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0049-3848(21)00374-110.1016/j.thromres.2021.06.014
?:doi
?:hasPublicationType
?:journal
  • Thrombosis research
is ?:pmid of
?:pmid
?:pmid
  • 34218058
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.096
?:rankingScore_hIndex
  • 99
?:title
  • Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all